Carregant...
Topiramate use does not reduce flares of inflammatory bowel disease
BACKGROUND: Additional medications are needed for inflammatory bowel disease (IBD), as existing therapies are incompletely effective and can be costly and toxic. Preclinical studies suggest that topiramate (an anticonvulsant) may have disease-modifying properties in IBD, but its efficacy in humans i...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4071112/ https://ncbi.nlm.nih.gov/pubmed/24504592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-014-3040-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|